Grape King Bio (TPE:1707) Accounts Payable: NT$364 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1707 Grape King Bio Ltd TPE:1707
79 GF Score
Price NT$91.40
GF Value NT$144.14
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Grape King Bio Accounts Payable?

Grape King Bio TPE:1707 -1.40% 79 Accounts Payable is NT$364 Mil as of Dec. 2025. GuruFocus rates TPE:1707 with a GF Score™ of 79/100 and a GF Value™ of NT$144.14 (Possible Value Trap). The stock has 5 warning signs investors should review.

Grape King Bio's Accounts Payable for the quarter that ended in Dec. 2025 was NT$364 Mil.

Grape King Bio's quarterly Accounts Payable increased from Jun. 2025 (NT$352 Mil) to Sep. 2025 (NT$382 Mil) but then declined from Sep. 2025 (NT$382 Mil) to Dec. 2025 (NT$364 Mil).

Grape King Bio's annual Accounts Payable increased from Dec. 2023 (NT$290 Mil) to Dec. 2024 (NT$309 Mil) and increased from Dec. 2024 (NT$309 Mil) to Dec. 2025 (NT$364 Mil).

Grape King Bio Accounts Payable Related Terms

Grape King Bio Accounts Payable Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Accounts Payable Chart

Grape King Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 268.96 293.84 290.10 309.44 363.91

Grape King Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 309.44 321.14 351.89 381.92 363.91
TPE:1707
79GF Score
Grape King Bio Ltd TPE:1707
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of NT$364 Mil mean?
Grape King Bio (TPE:1707) has a Accounts Payable of NT$364 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Grape King Bio and its competitors.
Is Grape King Bio's Accounts Payable too high?
Grape King Bio's current Accounts Payable is NT$364 Mil. Overall, Grape King Bio has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Accounts Payable compare to ZTS and UTHR?
Grape King Bio's Accounts Payable of NT$364 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Grape King Bio and its competitors. Grape King Bio's current Accounts Payable is NT$364 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.14, compared to a current price of NT$91.40 — trading 36.6% below its estimated fair value. The current Accounts Payable is NT$364 Mil. Grape King Bio's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Accounts Payable is NT$364 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$91.40 is trading 36.6% below its estimated GF Value™ of NT$144.14. GuruFocus considers Grape King Bio to be Possible Value Trap.

Key valuation signals for TPE:1707:

  • Accounts Payable: NT$364 Mil
  • GF Value™: NT$144.14 vs. price of NT$91.40 (36.6% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
79GF Score

Get the complete analysis for TPE:1707

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$91.40
Price
NT$144.14
GF Value